557330 Sigma-AldrichRolipram - CAS 61413-54-5 - Calbiochem
A cell-permeable, selective inhibitor of cAMP-specific phosphodiesterase (PDE IV; IC₅₀ = 800 nM).
More>> A cell-permeable, selective inhibitor of cAMP-specific phosphodiesterase (PDE IV; IC₅₀ = 800 nM). Less<<Synonyms: 4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
CAS # | Empirical Formula |
---|---|
61413-54-5 | C₁₆H₂₁NO₃ |
Pricing & Availability
Catalog Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
557330-5MG |
|
Plastic ampoule | 5 mg |
|
— |
Product Information | |
---|---|
CAS number | 61413-54-5 |
ATP Competitive | N |
Form | White solid |
Hill Formula | C₁₆H₂₁NO₃ |
Chemical formula | C₁₆H₂₁NO₃ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | PDE IV |
Primary Target IC<sub>50</sub> | 800 nM against cAMP-specific phosphodiesterase (PDE IV) |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | UY5749237 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalog Number | GTIN |
557330-5MG | 04055977267945 |
Documentation
Rolipram - CAS 61413-54-5 - Calbiochem SDS
Title |
---|
Rolipram - CAS 61413-54-5 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
557330 |
References
Reference overview |
---|
Navarro, J., et al. 1998. J. Virol. 72, 4712. Truong, V.H. and Muller, T. 1994. FEBS Lett. 353, 113. Underwood, D.C., et al. 1994. J. Pharmacol. Exp. Ther. 270, 250. Moore, J.B., Jr., et al. 1991. Biochem. Pharmacol. 42, 679. Reeves, M.L., et al. 1987. Biochem. J. 241, 535. Schneider, H.H., et al. 1986. Eur. J. Pharmacol. 127, 105. |